Repatha Evolocumab Demonstrates Reduced Need For Apheresis In Patients With...
THOUSAND OAKS Calif. March 13 2017 PRNewswire Amgen NASDAQ AMGN today announced positive topline results from a Phase 3 study evaluating Repatha evolocumab in patients who were receiving apheresis to...
View ArticleCVOT & Esperions Bempedoic Acid
We are writing this memo to summarize recent research concerning bempedoic acid ETC1002 and cardiovascular outcomes. Bempedoic acid is Esperions ESPR lead drug candidate for treating cardiovascular...
View ArticleAmerican Academy of Orthopaedic Surgeons Release Study Links High Cholesterol...
Life Sciences Jobs ...
View ArticleStudy links high cholesterol levels with rotator cuff surgery failure; statin...
SAN DIEGO Calif. March 14 2017 PRNewswireUSNewswire Patients with higher cholesterol levels face a significantly greater risk for failure of minimally invasive arthroscopic rotator cuff surgery...
View ArticleRepatha Evolocumab FourYear OpenLabel FollowUp Study Published In 'JAMA...
THOUSAND OAKS Calif. March 14 2017 PRNewswire Amgen NASDAQAMGN today announced that fouryear followup results from the Repatha evolocumab OSLER1 study the longest PCSK9 inhibitor clinical trial to...
View ArticleUse of Statins in Adults Older Than 75 YearsReply
In Reply Shared decision making is a cornerstone of optimal geriatric care especially when it comes to deciding on a lifelong treatment for which the available data do not fully allow for an...
View ArticleUse of Statins in Adults Older Than 75 Years
To the Editor As the title of the Viewpoint on statins for primary prevention in older adults indicated there is uncertainty and the need for more evidence in this important group. We are concerned...
View ArticleStatin Timing and Dosage May Improve Heart Surgery Outcomes
Patients on statins should not stop taking the cholesterollowering medication before heart surgeryeven on the day of surgery according to an article posted in The Annals of Thoracic Surgery.
View ArticleCANTABÂ assessments used in EBBINGHAUS cognitive function trial for Amgens...
16 March 2017 The neuroscience digital health company Cambridge Cognition Holdings PLC Cambridge UK LSE COG which develops and markets software products to improve brain health today reports its...
View ArticleEvolocumab significantly reduces risk of cardiovascular events
American College of Cardiology Evolocumab one of the new targeted PCSK9 inhibitor drugs that has been shown to dramatically lower levels of lowdensity lipoprotein LDL or 'bad' cholesterol also...
View ArticlePCSK9 inhibition with bococizumab yields mixed results
American College of Cardiology In a clinical program that was terminated early the experimental PCSK9 inhibitor bococizumab when given on top of effective statin therapy had widely varying effects on...
View ArticleLandmark Outcomes Study Shows That Repatha Evolocumab Decreases LDLC To...
THOUSAND OAKS Calif. March 17 2017 PRNewswire Amgen NASDAQAMGN today announced that the 27564patient Repatha evolocumab cardiovascular outcomes study FOURIER established for the first time that...
View ArticleGlobal Healthy Living Foundation Celebrates New FOURIER trial results...
Enthusiasm Tempered by Barriers Patients Face Accessing Evolocumab As Health Insurers Repeatedly Deny Prescription Claims The Global Healthy Living Foundation GHLF a nonprofit organization whose...
View ArticleACC.17 FOURIER trial meets primary endpoint but investors are not impressed
Although patients with atherosclerotic
View ArticleAdequatedose Statin Right Before CABG Linked to Improved Outcome
Statin treatment at adequate doses at least 24 hours prior to coronary artery bypass graft CABG surgery is associated with improved patient survival new research indicates. Reuters Health Information
View ArticleGuidelines differ on recommendations of statin treatment for AfricanAmericans
The JAMA Network Journals Approximately 1 in 4 AfricanAmerican individuals recommended for statin therapy under guidelines from the American College of CardiologyAmerican Heart Association are no...
View ArticleAfricanAmericans may receive different advice on statin therapy
Michigan Medicine University of Michigan Study investigates whether modern statin guidelines accurately identify African American patients with atherosclerotic cardiovascular disease.
View ArticleGuidelines May Miss Need for Statins in Many U.S. Blacks
SATURDAY March 18 2017 U.S. medical organizations have conflicting guidelines on the use of cholesterollowering statin drugs in blacks a new study finds.Researchers say that about one in four black...
View ArticleNo evidence of cognitive issues when evolocumab added to statin therapy
American College of Cardiology There is no evidence that adding a new cholesterollowering drug to treatment with a statin causes memory loss or other problems with cognition or thinking according to...
View ArticleEBBINGHAUS Evolocumab does not affect cognitive outcomes
WASHINGTON The addition of evolocumab to statin therapy did not result in memory loss or other cognitive issues according to results of the EBBINGHAUS study.The investigators of FOURIER which compared...
View Article